Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity
Open Access
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 25 (4) , 689-698
Abstract
No abstract availableKeywords
Funding Information
- Roswell Park Alliance Foundation
- National Cancer Institute (30-CA016056)
This publication has 28 references indexed in Scilit:
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction FailureJournal of Clinical Oncology, 2010
- Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical TrialsJournal of Clinical Oncology, 2010
- A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimensBlood, 2010
- 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2008
- Perspectives on cancer therapy-induced mucosal injuryCancer, 2004
- HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignanciesBlood, 2003
- Cellular and Clinical Pharmacology of FludarabineClinical Pharmacokinetics, 2002
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detectionBone Marrow Transplantation, 1999
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974